Ryan Wallis

2 weeks ago | biorxiv.org | Ryan Wallis |Bethany Hughes |Madeleine Moore |Emily O'Sullivan

AbstractBackgroundSenescence identification is rendered challenging due to a lack of universally available biomarkers. This represents a bottleneck in efforts to develop pro-senescence therapeutics - agents designed to induce the arrest of cellular proliferation associated with a senescence response in cancer cells for therapeutic gain.

Jan 14, 2025 | genomemedicine.biomedcentral.com | Bethany Hughes |Andrew Davis |Deborah Milligan |Ryan Wallis |Federica Mossa |Michael Philpott | +3 more

ReferencesHernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018;28:436–53. Article  PubMed  Google Scholar  González-Gualda E, Baker AG, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. 2021;288:56–80. Article  PubMed  Google Scholar  Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol. 2022;18:611–27.

Sep 24, 2024 | darlingmagazine.co.uk | Ryan Wallis

Just a few decades ago, women were often underrepresented in traditional business areas. Today, the tide has turned. Online business offers a flexible and scalable platform where women can successfully build a career without having to overcome the challenges of the traditional world of work, such as rigid working hours or work-life balance.

Sep 13, 2024 | nature.com | Ryan Wallis |Federica Mossa

AbstractSenescence is an anti-tumour mechanism and hallmark of cancer. Loss or mutation of key senescence effectors, such as p16INK4A, are frequently observed in cancer. Intriguingly, some human tumours are both proliferative and senescent-marker positive (Sen-Mark+). Here, we explore this paradox, focusing on the prognostic consequences and the current challenges in classifying these cells.

Apr 14, 2024 | newsbreak.com | Ryan Wallis

Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.